open
MOLBIO DIA

Molbio Diagnostics IPO

Molbio Diagnostics is an innovative point-of-care (POC) diagnostics company that develops affordable, rapid, and accurate diagnostic solutions for infectious and non-communicable diseases. Its flagship product, Truenat, is a portable, battery-powered PCR testing platform that delivers results within an hour. Designed for use in resource-limited settings, it enables quick and decentralised disease diagnosis at the point of care.

Advertisement (Slot: header)

Price Band

🔴

Lot Size

0 Shares

Issue Size

Approx ₹939.70 Crores

Current GMP

₹120 (Aug 18)

IPO Timeline

Open DateAugust 18, 2026
Close DateAugust 18, 2026
Basis of AllotmentTBA
Listing DateJanuary 1, 2026

Subscription Status

Overall subscription

Promoters

ParticularPre IPO SharesPre IPO % SharesPost IPO SharesPost IPO % Shares
Promoter and Promoter Group52,597,45046.65%4,34,31,45037.69%
Others*60,162,30053.35%7,18,08,54662.31%
Total11,27,59,750100%11,52,39,996100%

Objects of the Issue

  • Kotak Mahindra Capital Co. Ltd.
  • IIFL Capital Services Ltd.
  • Jefferies India Pvt. Ltd.
  • Motilal Oswal Investment Advisors Ltd.

Open Demat Account to Apply

Advertisement (Slot: sidebar)